3 Stocks Driving The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 78 points (-0.5%) at 14,583 as of Wednesday, April 3, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 720 issues advancing vs. 2,193 declining with 115 unchanged.

The Health Services industry currently sits down 1.0% versus the S&P 500, which is down 0.7%. Top gainers within the industry include Intuitive Surgical ( ISRG), up 2.5%, St Jude Medical ( STJ), up 1.0%, Aetna ( AET), up 0.6% and Agilent Technologies ( A), up 0.6%. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 5.9%, HCA Holdings ( HCA), down 4.7%, Health Management Associates ( HMA), down 4.0%, Community Health Systems ( CYH), down 4.1% and Universal Health Services ( UHS), down 2.4%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry higher today:

3. Fresenius Medical Care AG & Co. KGaA ( FMS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care AG & Co. KGaA is up $0.37 (1.1%) to $34.77 on average volume Thus far, 89,214 shares of Fresenius Medical Care AG & Co. KGaA exchanged hands as compared to its average daily volume of 218,900 shares. The stock has ranged in price between $34.66-$34.94 after having opened the day at $34.81 as compared to the previous trading day's close of $34.40.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis products for the treatment of end-stage renal disease. Fresenius Medical Care AG & Co. KGaA has a market cap of $10.2 billion and is part of the health care sector. The company has a P/E ratio of 17.5, below the S&P 500 P/E ratio of 17.7. Shares are up 0.3% year to date as of the close of trading on Tuesday. Currently there are 4 analysts that rate Fresenius Medical Care AG & Co. KGaA a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Fresenius Medical Care AG & Co. KGaA as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Fresenius Medical Care AG & Co. KGaA Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you liked this article you might like

Mining and Resources Lead Europe's Benchmarks Lower

European Stocks Diverge as Investors Weigh Economic Optimism With Mixed Earnings

Wednesday's Earnings Push Stocks Lower as Mood Sours in Europe

Here's What's Boosting European Benchmarks

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space